Q3 Results 09th Feb Live: BSE, Zydus Lifesciences, Aurobindo Pharma, Linde India, Axiscades Tech, GlaxoSmithKline Pharma, Navin Fluorine Intl, Cholamandalam Financial Holdings, Ramco Cements, Amber Enterprises, Trident, Graphite India, Bata to announce Q3 results

Q3 results dwell: Pearl World Industries Restricted annpunces their Q3 efficiency

The shares of Pearl World Industries Restricted had been buying and selling on the NSE at the moment at ₹1,778.70 down by ₹56.10 or 3.06 per cent submit the results. 

Consolidated Financial Highlights for 9MFY26: Income stands at ₹3,711 crore, progress of 13.2 per cent Y-o-Y, pushed by excessive value-added product gross sales progress in Vietnam and Indonesia 

Adj. EBITDA (excl. ESOP expense) stands at ₹333 crore, grew by 14.0 per cent Y-o-Y, EBITDA margin at ~9.0 per cent 

Adj. EBITDA margin excluding reciprocal tariff impression of ~₹31 crore and incremental ramping up price of latest operations of ~₹11 crore, stands at ~10.1 per cent 

PAT grew to ₹189 crore, up 14.0 per cent Y-o-Y 

Consolidated Financial Highlights for Q3FY26: Income stands at ₹1,170 crore, grew by 14.4 per cent Y-o-Y 

Adj. EBITDA (excl. ESOP expense) got here at ₹97 crore, up 4.4 per cent Y-o-Y, with margin at 8.3 per cent 

Adj. EBITDA margin excluding reciprocal tariff impression and incremental ramping up price of latest operations of ~₹9 crore stands at ~9.1 per cent 

PAT grew to ₹52 crore, up 6.8 per cent Y-o-Y 

Standalone Financial Highlights for 9MFY26: Income stands at ₹777 crore 

Adj. EBITDA (excl. ESOP expense) stands at ₹43 crore, grew by 63.7 per cent Y-o-Y, EBITDA margin of 5.5 per cent, improved by 220 BPS Y-o-Y, primarily due to price restructuring 

Adj. EBITDA margin excluding reciprocal tariff price of ₹~14 crore stands at ~7.3 per cent 

PAT stands at ₹55 crore, in contrast to ₹32 crore in 9M FY25 

Standalone Financial Highlights for Q3FY26: Income stands at ₹246 crore 

Adj. EBITDA stands at ₹13 crore, EBITDA margin at 5.1 per cent, improved by 140 BPS Y-o-Y 

Adj. EBITDA margin excluding reciprocal tariff price of ₹~5 crore stands at ~7.2 per cent 

PAT stands at ₹14 crore, in contrast to ₹4 crore in Q3 FY25 

Q3 results dwell: Procter & Gamble Well being Ltd. (PGHL) introduced their results

The shares of Procter & Gamble Well being Ltd. (PGHL) had been buying and selling at ₹5,249.50 up by ₹59.50 or 1.15 per cent.

Procter & Gamble Well being Ltd. (PGHL) at the moment introduced its monetary results for the third quarter ended December 31, 2025. The Firm delivered gross sales of ₹368 crores, up 21 per cent versus a yr in the past, pushed by robust model fundamentals and optimistic shopper response to new improvements. Revenue After Tax (PAT) stood at ₹78 crores for the quarter. 

Q3 results dwell: Filatex India Restricted announved its results on Saturday.

The shares of Filatex India Restricted had been buying and selling on the NSE at the moment within the morning at ₹51.77 up by ₹3.62 or 7.52 per cent. 

Standalone income from operations stood at ₹1,049.70 crore for Q3FY26 and ₹3175.03 crore for 9MFY26. EBITDA was reported at ₹93.58 crore with a margin of 8.91 per cent for Q3FY26 and ₹260.27 crore for 9MFY26, up 43.02 per cent YoY. PAT stood at ₹55.34 crore with a margin of 5.27 per cent for Q3FY26 and ₹143.65 crore for 9MFY26, up 54.15 per cent YoY.

Filatex India Restricted, is an built-in, ESG-aligned polyester filament yarn producer pioneering India’s next-generation round supplies ecosystem, exporting to 40+ international locations. 

In the course of the quarter, Filatex made progress on its Ecosis textile-to-textile round recycling platform, superior sustainability and renewable vitality initiatives, and continued its engagement with Decathlon as a key international buyer.